Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

With No Big Push For R&D Or Infrastructure, Indian Budget Belies Pharma Industry Hopes

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - The keenly watched "Union Budget" of the Indian government made no direct references or moves that could benefit the Indian pharmaceutical industry - leaving most senior level executives disappointed and hoping for progressive steps in the future

You may also be interested in...



Are Biosimilars The Next Big Opportunity In India?

MUMBAI - The Indian biosimilars market is a multi-billion dollar opportunity for Indian and multinational companies to tap into, albeit via different routes, according to a white paper released this month by global consultancy Frost & Sullivan

Are Biosimilars The Next Big Opportunity In India?

MUMBAI - The Indian biosimilars market is a multi-billion dollar opportunity for Indian and multinational companies to tap into, albeit via different routes, according to a white paper released this month by global consultancy Frost & Sullivan

Only Private Industry Can Reach India's Rural Population As Government Focuses On Disease Prevention

HONG KONG - Trying to improve the quality of its healthcare services, India plans to reach out to its vast rural population while looking to create partnership opportunities within the private sector

Related Content

UsernamePublicRestriction

Register

SC077256

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel